Neurobiology of Cocaine Addiction

https://pmc.ncbi.nlm.nih.gov/articles/PMC2851032/

Summary

  • Cocaine primarily affects the limbic system — the brain’s pleasure and motivation circuit.

  • The dopamine build up causes euphoria and reinforces drug-taking behaviour.

  • Long-term effects involve changes in gene expression and neuron structure, which underlie addiction and relapse.

Cocaine’s Immediate Effects - Dopamine Build up

  • Cocaine blocks the dopamine transporter, preventing reuptake.

  • Dopamine accumulates → overstimulation of receptor neurons → pleasure/high.

  • Also affects serotonin and norepinephrine, but dopamine is key.

  • The dopamine system is evolutionarily ancient—central to survival behaviours.

The Limbic System

Key Regions:

  • Nucleus accumbens (NAc): produces pleasure/reward feelings.

  • Amygdala & Hippocampus: create emotional and memory associations with drug cues.

  • Frontal Cortex: controls impulses and decision-making (“the brake”).

    • Becomes impaired in addiction → weaker self-control.

Result:

  • Repeated use → powerful memory associations → craving.

  • Drug cues (places, people, objects) trigger relapse through learned responses.

Intermediate Effects: Changes in Gene Expression

Gene Activation:

  • Cocaine alters the expression of multiple genes in the NAc.

  • One critical factor: ΔFosB (genetic transcription factor).

ΔFosB’s Role:

  • Builds up with repeated cocaine use.

  • Lasts 6–8 weeks, accumulating with continued exposure.

  • Acts as a molecular “switch” in transitioning from abuse → addiction.

Evidence:

  • Mice with elevated ΔFosB show addiction-like behaviours:

    • More sensitivity, self-administration, and craving.

  • Blocking ΔFosB reduces addictive behaviours.

Mechanisms:

  • ΔFosB regulates over 100 genes in the NAc.

  • Promotes expression of CDK5, an enzyme driving nerve cell growth.

Long-Term Effects: Structural Brain Changes

  • Chronic cocaine use → growth of new dendritic spines in NAc neurons.

  • Structural changes enhance signal input from other brain regions (amygdala, hippocampus).

  • Explains long-term craving and relapse vulnerability.

  • ΔFosB and CDK5 likely mediate this neuronal growth.

Genetic Vulnerability

  • About 50% of addiction risk is genetic.

  • Candidate genes: those regulating ΔFosB or dopamine/glutamate systems.

  • Stress also increases risk but interacts variably with genetic factors.

Clinical Implications

Current Treatments:

  • Focus mainly on acute effects, e.g.:

    • Cocaine vaccines – block entry to brain.

    • Transporter inhibitors – prevent dopamine reuptake without euphoria.

    • Receptor drugs – target dopamine receptor subtypes.

  • No definitive success yet.

Future Approaches:

  • Target long-term neurobiological changes (e.g., ΔFosB, CDK5, glutamate receptors).

  • Developing drugs may take 10–20 years but offers best hope.

Psychological & Biological Integration

  • Addiction is both biological and psychosocial.

  • Biological treatments needed to counteract altered brain function.

  • Psychosocial support remains essential for recovery.

Overall

  • Cocaine hijacks the brain’s reward system by over activating dopamine in the limbic system.

  • Chronic use alters gene expression and neuron structure, sustaining addiction.

  • ΔFosB acts as a long-lasting molecular switch driving addiction and relapse.

  • Future treatments aim to reverse these molecular and structural changes.